John S. Montalbano - Mar 1, 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
/s/ Tryn Stimart, attorney in fact
Stock symbol
ABCL
Transactions as of
Mar 1, 2022
Transactions value $
$181,000
Form type
4
Date filed
3/3/2022, 11:06 AM
Previous filing
Dec 10, 2021
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $181K +20K +76.92% $9.05 46K Mar 1, 2022 Direct
holding ABCL Common Shares 5K Mar 1, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.